虽然IBD的确切原因尚不清楚,有许多因素被认为有助于其发展,包括环境和遗传因素。虽然独家肠内营养(EEN)是一种有前途的治疗克罗恩病(CD),它还没有被认为是一线治疗。此外,与皮质类固醇治疗相比,EEN的疗效仍在研究中.EEN被建议作为一线治疗的指南和年龄组,因为它可能在儿科和成人的建议不同。另一个发现是,涉及抗炎食物增加和炎性化合物含量高的食物摄入量减少的饮食变化与缓解期溃疡性结肠炎(UC)患者的代谢和微生物学有益结果有关。有关医学文献,我们检查了PubMed/Medline,Cochrane图书馆,和谷歌学者作为医疗数据库的例子。文章被识别,评估,和申请资格,发现了九种出版物。完成的文章研究了几种饮食选择对IBD患者的作用。其他一些研究表明,遵循正常的低脂肪饮食可能有效减少亚临床结肠炎的发生。EEN和部分肠内营养(PEN)表明两种方案之间没有显着差异,但两者在活动性IBD期间均有良好的结果.其他严格的饮食,例如特定的碳水化合物饮食(SCD)与地中海饮食(MD),在IBD患者中表现出良好的预后。可发酵寡糖,二糖,单糖,和多元醇(FODMAP)饮食咨询可改善IBD患者的胃肠道症状和生活质量。根据上述情况,我们得出的结论是,更多的研究确定饮食的哪个成分尚不清楚(蛋白质,碳水化合物平衡)或饮食类型需要建立特定的饮食作为这些个体的治疗干预。
While the exact cause of IBD is unknown, there are a number of factors that are thought to contribute to its development, including environmental and genetic factors. While exclusive enteral nutrition (EEN) is a promising therapy for Crohn\'s disease (CD), it is not yet considered a first-line treatment. Additionally, the efficacy of EEN compared to corticosteroid treatment is still being investigated. EEN is suggested as a first-line therapy by which guidelines and in which age groups, as it may differ in pediatric and adult recommendations. Another finding was that dietary changes involving an increase in anti-inflammatory foods and decreased intake of foods high in inflammatory compounds are linked to a beneficial outcome both metabolically and microbiologically in patients with ulcerative colitis (UC) in remission. For relevant medical literature, we examined PubMed/Medline, the Cochrane Library, and Google Scholar as examples of medical databases. The articles were identified, evaluated, and eligibility applied, and nine publications were found. The finished articles investigated the role of several diet alternatives for patients with IBD. Some others have shown that following a normal low-fat diet may be effective in reducing the occurrence of subclinical colitis. The EEN and partial enteral nutrition (PEN) indicated no significant differences between both regimens, but both had good outcomes during active IBD. Other strict diets, such as the specific carbohydrate diet (SCD) versus the Mediterranean diet (MD), demonstrate excellent outcomes in patients with IBD. Fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) dietary counseling improves gastrointestinal symptoms and quality of life in IBD patients. Based on the above, we concluded that more studies determining which component of the diet is not clear (proteins, carbs balanced) or diet types are required to establish a particular diet employed as a treatment intervention in these individuals.